Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)
China flag China · Delayed Price · Currency is CNY
11.53
+0.03 (0.26%)
Feb 4, 2026, 3:00 PM CST

SHA:603811 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
788.8712.31669.61653.25693.45757.43
Other Revenue
2.062.062.011.720.520.7
790.86714.37671.63654.97693.96758.13
Revenue Growth (YoY)
7.94%6.36%2.54%-5.62%-8.46%11.29%
Cost of Revenue
237.27225.17248.45217.8208.98206.41
Gross Profit
553.59489.2423.17437.17484.99551.72
Selling, General & Admin
325.25308.66246.92269.61280.27344.57
Research & Development
41.8647.0847.1444.339.7231.79
Other Operating Expenses
17.2512.347.467.7710.79.68
Operating Expenses
383.71365.77302.46321.83331.21387.13
Operating Income
169.88123.43120.71115.34153.78164.59
Interest Expense
-5.79-11.09-15.26-9.13-4.52-4.96
Interest & Investment Income
40.6246.2867.1249.0831.8724.36
Currency Exchange Gain (Loss)
0.010.01-0.173.455.36-0.62
Other Non Operating Income (Expenses)
-0.13-0.07-0.31-0.11-0.99-0.21
EBT Excluding Unusual Items
204.59158.56172.1158.62185.49183.16
Impairment of Goodwill
----2.42-2.92-4.92
Gain (Loss) on Sale of Investments
----3.5510.69-
Gain (Loss) on Sale of Assets
60.6769.17-00.06-0.450
Asset Writedown
-27.65-24-7.47-0.41-0.5-3.21
Other Unusual Items
14.1214.49.4411.535.1913.86
Pretax Income
251.72218.13174.06163.84197.5188.89
Income Tax Expense
23.3317.3512.012.6626.2723.94
Earnings From Continuing Operations
228.38200.79162.05161.18171.23164.95
Minority Interest in Earnings
-2.03-0.090.850.4-0.430.19
Net Income
226.35200.7162.9161.58170.8165.14
Net Income to Common
226.35200.7162.9161.58170.8165.14
Net Income Growth
36.34%23.21%0.81%-5.39%3.42%25.69%
Shares Outstanding (Basic)
323329326330328326
Shares Outstanding (Diluted)
323329326330328326
Shares Change (YoY)
-0.78%0.99%-1.20%0.67%0.59%-0.09%
EPS (Basic)
0.700.610.500.490.520.51
EPS (Diluted)
0.700.610.500.490.520.51
EPS Growth
37.41%22.00%2.04%-6.02%2.82%25.80%
Free Cash Flow
275.95145.83123.93-86.929.3834.13
Free Cash Flow Per Share
0.850.440.38-0.260.030.10
Dividend Per Share
0.2500.2500.2000.1790.1790.179
Dividend Growth
25.00%25.00%11.98%--22.50%
Gross Margin
70.00%68.48%63.01%66.75%69.89%72.77%
Operating Margin
21.48%17.28%17.97%17.61%22.16%21.71%
Profit Margin
28.62%28.09%24.25%24.67%24.61%21.78%
Free Cash Flow Margin
34.89%20.41%18.45%-13.27%1.35%4.50%
EBITDA
277.37217.99198.04176.89208.45212.46
EBITDA Margin
35.07%30.52%29.49%27.01%30.04%28.02%
D&A For EBITDA
107.594.5677.3261.5554.6747.87
EBIT
169.88123.43120.71115.34153.78164.59
EBIT Margin
21.48%17.28%17.97%17.61%22.16%21.71%
Effective Tax Rate
9.27%7.95%6.90%1.62%13.30%12.68%
Revenue as Reported
790.86714.37671.63654.97693.96758.13
Advertising Expenses
-3.851.810.891.411.41
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.